Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells | BMC Cancer | Full Text

Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells | BMC Cancer | Full Text

Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells

There are many types of therapies for cancer. In these days, immunotherapies, especially immune checkpoint inhibitors, are focused on. Though many types of immune checkpoint inhibitors are there, the differenc...

Authors:Kazushige Yoshida, Masanori Okamoto, Jun Sasaki, Chika Kuroda, Haruka Ishida, Katsuya Ueda, Hirokazu Ideta, Takayuki Kamanaka, Atsushi Sobajima, Takashi Takizawa, Manabu Tanaka, Kaoru Aoki, Takeshi Uemura, Hiroyuki Kato, Hisao Haniu and Naoto Saito

Citation:BMC Cancer 2020 20:25

Content type:Research article

Published on: 8 January 2020

• ViewFull Text
 
• ViewPDF